Biosimilars Council

And that's a wrap! 🎉 Thank you to our AAM event planning team, all attendees, every dedicated sponsor and the speakers, panelists and moderators who truly are the future of generic and biosimilar medicines. YOU are driving what's next for the generic and biosimilar medicines industry—and we are thrilled to see the positive impact we can bring to America's patients when we all work together toward better access to lower-cost prescription medicines. Thanks again for joining us in sunny South Florida! ☀️ Get home safely, everyone!

With thanks to Keren Haruvi for her dedication and success as former AAM Board Chair, we are now thrilled to welcome Bob Hoffman of Lupin Pharmaceuticals – as our new Chairman of the AAM Board of Directors! Bob most recently served as Vice-Chair with our AAM board, and we are greatly looking forward to all the future holds under his leadership. Congrats to you, Bob!

Please join us in a giant a digital round of applause for Tirzah Duren, President and CEO, accepting on behalf of American Consumer Institute—our Champions of Access Award recipient.